News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eisai Company, Ltd. (ESALY.PK) Puts $200 Million into US Personalised Medicine Unit


1/31/2011 8:32:02 AM

Pharma Times -- Eisai has formed a biotech start-up in the USA, H3 Biomedecines, which will focus on discovering and developing next-generation cancer drugs.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES